MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Small Cell Lung Cancer

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 62
  • Start Date: September 1, 2020
A Phase Ib Dose-Escalation and Dose-Expansion Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Patients With Untreated Extensive-Stage Small Cell Lung Cancer.
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 58
  • Start Date: August 31, 2020
A Multi-Center, Phase I/II Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 324
  • Start Date: August 17, 2020
Randomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Clinical Trial
Behavioral
  • Status: Recruiting
  • Study Type: Behavioral
  • Participants: 45
  • Start Date: August 1, 2020
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 104
  • Start Date: July 28, 2020
Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease: a Randomized, Open-label, Multicenter Phase II Study
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 91
  • Start Date: July 16, 2020
Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumors and NSCLC: An Open Label Phase IA/IB Study. Preserve CTLA4 Checkpoint Function (PRESERVE-001)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 110
  • Start Date: July 15, 2020
A First -in Human Phase I, Non-randomized, Open-label, Multi-center Dose Escalation Trial of BI 764532 Administered by Repeated Intravenous Infusions in Patients With Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 135
  • Start Date: July 14, 2020
A Phase 2, Multicenter, Open-label, Multi-cohort Study to Assess Safety and Efficacy of CC-90011 in Combination With Checkpoint Inhibitor(s) in Subjects With Advanced Cancers
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 100
  • Start Date: June 30, 2020
A Phase 1b Study of Venetoclax in Combination With Pembrolizumab in Subjects With Previously Untreated NSCLC Whose Tumors Have High PD-L1 Expression
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: June 29, 2020
Radiation Enhancement of Local and Systemic Anti-Prostate Cancer Immune Responses
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 60
  • Start Date: June 19, 2020
Phase 1/2a, First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety, PK, PD, and Preliminary Efficacy of BNT411 as a Monotherapy in Patients With Solid Tumors and in Combination With Atezolizumab, Carboplatin and Etoposide in Patients With Chemotherapy-naïve ES-SCLC
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 81
  • Start Date: June 18, 2020
An Open-label, Multi-center, Phase 2 Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection (PLM60) in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy
Showing 1–12 of 308 Clinical Trials
Next